These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 17761046)
21. Cost-benefit analysis of hepatitis a vaccination in Thailand. Teppakdee A; Tangwitoon A; Khemasuwan D; Tangdhanakanond K; Suramaethakul N; Sriratanaban J; Poovorawan Y Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):118-27. PubMed ID: 12118439 [TBL] [Abstract][Full Text] [Related]
22. Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates. Jacobs RJ; Rosenthal P; Meyerhoff AS Vaccine; 2004 Mar; 22(9-10):1241-8. PubMed ID: 15003653 [TBL] [Abstract][Full Text] [Related]
23. Economic evaluations of hepatitis A vaccination in middle-income countries. Suwantika AA; Yegenoglu S; Riewpaiboon A; Tu HA; Postma MJ Expert Rev Vaccines; 2013 Dec; 12(12):1479-94. PubMed ID: 24168129 [TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of hepatitis A vaccination for adults in Belgium. Luyten J; Van de Sande S; de Schrijver K; Van Damme P; Beutels P Vaccine; 2012 Sep; 30(42):6070-80. PubMed ID: 22858555 [TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness analysis of catch-up hepatitis A vaccination among unvaccinated/partially-vaccinated children. Hankin-Wei A; Rein DB; Hernandez-Romieu A; Kennedy MJ; Bulkow L; Rosenberg E; Trigg M; Nelson NP Vaccine; 2016 Jul; 34(35):4243-4249. PubMed ID: 27317459 [TBL] [Abstract][Full Text] [Related]
26. Seven-year follow-up of the immune response after one or 2 doses of inactivated hepatitis A vaccine given at 1 year of age in the Mendoza Province of Argentina. Espul C; Benedetti L; Linares M; Cuello H; Lo Castro I; Thollot Y; Rasuli A Hum Vaccin Immunother; 2017 Nov; 13(11):2707-2712. PubMed ID: 28933624 [TBL] [Abstract][Full Text] [Related]
27. Incidence of Hepatitis A in Argentina after vaccination. Vacchino MN J Viral Hepat; 2008 Oct; 15 Suppl 2():47-50. PubMed ID: 18837834 [TBL] [Abstract][Full Text] [Related]
28. The cost-effectiveness of universal vaccination of children against hepatitis A in Argentina: results of a dynamic health-economic analysis. Lopez E; Debbag R; Coudeville L; Baron-Papillon F; Armoni J J Gastroenterol; 2007 Feb; 42(2):152-60. PubMed ID: 17351805 [TBL] [Abstract][Full Text] [Related]
29. Economic evaluation of a publicly funded hepatitis A travel vaccination program in Ontario, Canada. Ramsay LC; Anyiwe K; Li M; Macdonald L; Coyte PC; Sander B Vaccine; 2019 Mar; 37(11):1467-1475. PubMed ID: 30770225 [TBL] [Abstract][Full Text] [Related]
30. Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach. Hayajneh WA; Daniels VJ; James CK; Kanıbir MN; Pilsbury M; Marks M; Goveia MG; Elbasha EH; Dasbach E; Acosta CJ BMC Infect Dis; 2018 Mar; 18(1):119. PubMed ID: 29514609 [TBL] [Abstract][Full Text] [Related]
31. Cost-utility analysis of hepatitis A prevention among health-care workers in Israel. Chodick G; Lerman Y; Wood F; Aloni H; Peled T; Ashkenazi S J Occup Environ Med; 2002 Feb; 44(2):109-15. PubMed ID: 11851212 [TBL] [Abstract][Full Text] [Related]
32. Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands). Postma MJ; Bos JM; Beutels P; Schilthuis H; van den Hoek JA Vaccine; 2004 May; 22(15-16):1862-7. PubMed ID: 15121296 [TBL] [Abstract][Full Text] [Related]
33. Immunization Against Hepatitis A in Migrant Children: Three Vaccination Strategies, A Retrospective Study. Fahrni O; Posfay-Barbe KM; Wagner N Pediatr Infect Dis J; 2020 Feb; 39(2):164-169. PubMed ID: 31929432 [TBL] [Abstract][Full Text] [Related]
34. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States. Arguedas MR; Heudebert GR; Fallon MB; Stinnett AA Am J Gastroenterol; 2002 Mar; 97(3):721-8. PubMed ID: 11922569 [TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of Hepatitis A vaccination in a developed and developing country. Ghildayal N Int J Health Care Qual Assur; 2019 Oct; 32(8):1175-1199. PubMed ID: 31566514 [TBL] [Abstract][Full Text] [Related]
36. Modeling the long-term persistence of hepatitis A antibody after a two-dose vaccination schedule in Argentinean children. López EL; Contrini MM; Mistchenko A; Kieffer A; Baggaley RF; Di Tanna GL; Desai K; Rasuli A; Armoni J Pediatr Infect Dis J; 2015 Apr; 34(4):417-25. PubMed ID: 25764099 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness of hepatitis A vaccination as post-exposure prophylaxis. Parrón I; Planas C; Godoy P; Manzanares-Laya S; Martínez A; Sala MR; Minguell S; Torner N; Jané M; Domínguez A; Hum Vaccin Immunother; 2017 Feb; 13(2):423-427. PubMed ID: 27925847 [TBL] [Abstract][Full Text] [Related]
38. Cost-effective analysis of hepatitis A vaccination in Kerala state, India. Gurav YK; Bagepally BS; Chitpim N; Sobhonslidsuk A; Gupte MD; Chaikledkaew U; Thakkinstian A; Thavorncharoensap M PLoS One; 2024; 19(6):e0306293. PubMed ID: 38935781 [TBL] [Abstract][Full Text] [Related]
39. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years. Kurugöl Z; Mutlubaş F; Ozacar T Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736 [TBL] [Abstract][Full Text] [Related]
40. [Epidemiology and cost-effectiveness analysis of hepatitis A vaccination in Liuzhou City]. Li X; Xu Z; Hofman A Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Apr; 19(2):93-6. PubMed ID: 10322718 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]